Why the study?
Reports indicate suspended skeletal and cardiac myosin act as procoagulants, raising the question of whether purified muscle myosins retain procoagulant phospholipid through purification.
Does contaminating phospholipid account for the procoagulant activities of skeletal and cardiac muscle myosin?
Does contaminating phospholipid account for the procoagulant activities of skeletal and cardiac muscle myosin?
The procoagulant activity of purified skeletal and cardiac myosin is indirectly mediated by contaminating phospholipid and tissue factor-like activity, suggesting an affinity of myosin for phospholipid membranes.
Contaminating phospholipid likely mediates myosin procoagulant activity in vitro; leaves open any direct role in thrombosis.
Recent reports indicate that suspended skeletal and cardiac myosin, such as might be released during injury, can act as procoagulants by providing membrane-like support for factors Xa and Va in the prothrombinase complex. Further, skeletal myosin provides membrane-like support for activated protein C. This raises the question of whether purified muscle myosins retain procoagulant phospholipid through purification. We found that lactadherin, a phosphatidyl-l-serine-binding protein, blocked >99% of prothrombinase activity supported by rabbit skeletal and by bovine cardiac myosin. Similarly, annexin A5 and phospholipase A2 blocked >95% of myosin-supported activity, confirming that contaminating phospholipid is required to support myosin-related prothrombinase activity. We asked whether contaminating phospholipid in myosin preparations may also contain tissue factor (TF). Skeletal myosin supported factor VIIa cleavage of factor X equivalent to contamination by ∼1:100 000 TF/myosin, whereas cardiac myosin had TF-like activity >10-fold higher. TF pathway inhibitor inhibited the TF-like activity similar to control TF. These results indicate that purified skeletal muscle and cardiac myosins support the prothrombinase complex indirectly through contaminating phospholipid and also support factor X activation through TF-like activity. Our findings suggest a previously unstudied affinity of skeletal and cardiac myosin for phospholipid membranes.
No takes yet. Share an insight, caveat, or question.
Novakovic et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: